Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-09-014270
Filing Date
2009-01-29
Accepted
2009-01-29 16:53:29
Documents
2
Period of Report
2009-01-22
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K AMENDMENT NO. 1 d8ka.htm 8-K/A 34957
2 CONSENT OF KPMG LLP dex231.htm EX-23.1 2405
  Complete submission text file 0001193125-09-014270.txt   39030
Mailing Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021
Business Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-22873 | Film No.: 09554998
SIC: 2835 In Vitro & In Vivo Diagnostic Substances